TMEM168 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.59570000049614E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.49460000001367E-06 |
Normal-vs-Stage2 |
1.080260E-03 |
Normal-vs-Stage3 |
4.49139999636472E-08 |
Normal-vs-Stage4 |
7.40130001730677E-09 |
Stage1-vs-Stage2 |
7.596600E-01 |
Stage1-vs-Stage3 |
9.809700E-02 |
Stage1-vs-Stage4 |
5.823700E-03 |
Stage2-vs-Stage3 |
1.954220E-01 |
Stage2-vs-Stage4 |
6.823500E-02 |
Stage3-vs-Stage4 |
4.935400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.99780000045935E-07 |
Normal-vs-AfricanAmerican |
3.73540000042638E-07 |
Normal-vs-Asian |
8.650200E-02 |
Caucasian-vs-AfricanAmerican |
5.180800E-01 |
Caucasian-vs-Asian |
8.724200E-01 |
AfricanAmerican-vs-Asian |
6.425600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.6098999994506E-07 |
Normal-vs-Female |
8.03960000017589E-07 |
Male-vs-Female |
6.342000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.22669999608394E-08 |
Normal-vs-Age(41-60Yrs) |
5.47550000007391E-07 |
Normal-vs-Age(61-80Yrs) |
1.17659999998576E-06 |
Normal-vs-Age(81-100Yrs) |
2.07609999999248E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.402100E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.717900E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.691800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.334400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.543400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.014400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.317700E-02 |
Normal-vs-Grade 2 |
1.77949999999871E-05 |
Normal-vs-Grade 3 |
4.29309999772087E-08 |
Normal-vs-Grade 4 |
1.94020355337443E-11 |
Grade 1-vs-Grade 2 |
9.404000E-01 |
Grade 1-vs-Grade 3 |
2.176600E-01 |
Grade 1-vs-Grade 4 |
3.581400E-03 |
Grade 2-vs-Grade 3 |
2.775500E-03 |
Grade 2-vs-Grade 4 |
1.40420000072083E-08 |
Grade 3-vs-Grade 4 |
5.837700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.354900E-04 |
Normal-vs-ccB subtype |
4.63879999967887E-08 |
ccA subtype-vs-ccB subtype |
4.581100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.20019999996879E-06 |
Normal-vs-N1 |
6.984300E-04 |
N0-vs-N1 |
1.318150E-01 |
|
|